there is like 1 real basher here and it's studio/bb. everyone else doesn't really care but just watching.
they should have done a deal a while ago but the bond holders were not playing ball and everyone got hurt.
and look, for most of the "bashers" from back in 2007 does it really matter if the stock is 6 cents or 60 cents? the stock was 250 bucks (incorporating the reverse split). a home run.
the most recent bashers in the past 3-5 years are just here to see the train wreck.
okay, i see... you are expecting a big price. still confused on your math but i assume you can do it correctly. i get 2.4mm profit from 20k shares with profit of 120 per share.
i am rather suprised that the company did not disclose the fact that they did not pay interest on their debt for over 6 weeks. i would think shareholders should give the company major grief over this.
stock was surprisingly strong today given the news. i guess it's hard to sell at 7 cents if you owned it at 160 pre reverse split.
good luck longs.
they have ramped up huge in terms of employees. look at the increase. mostly in sales. the ramp up in europe is also huge.
As of December 31, 2015, we had 405 employees, of which 216 employees were in our drug development operations, 117employees were in our commercial group and 72 employees were in our corporate group. As of December 31, 2015, 309 employeeswere based in the United States, 89 employees were based in Europe and 7 employees were based in Canada.
As of December 31, 2014, we had 136 employees, of which 92 employees were in our drug development operations, 18 employeeswere in our commercial group and 26 employees were in our corporate group.
most sell side models assume approval already. what's the big deal if it's this week or in 3 weeks.. the value is in the NASH drug if it works
now i am trying to figure out how much off label prescription will be done. i am assuming zero for now. but this could be potentially good source of revenue in 2017-2018. won't change long term picture.
6b is what they will get i think. that's 240 bucks.. ideally it's 6b excluding the cash on the balance sheet which adds another 20 bucks. that's 260. i would love that price.
the question is do we have to wait for the old man to die before anything changes? or is the son going to continue the same path. i don't think a dividend is happening although it would be nice. i think modest share buybacks instead of writing terrible new business is the most appropriate thing. also having a conference call would also be good.
which sell side has 2.2b for pbc. csfb is north of 1b. bmo is 900mm. i am using 750mm. that gets me to my 150 downside price... the upside cases you highlight are crazy high.
if we had a modest dividend i think shareholders would be happy. the other smarter idea is to have capital plan to return capital to shareholders when opportunities are limited.
have these option plays worked out for you in the past?
GILD has been focusing heavily on NASH - what's to think they are interested in spending multi billion dollars on another line of therapy?
you are smoking crack on 750!! although i would not complain at that as i probably make 25mm or so at those levels. i think probably a 10-15% chance of a take out and my target price is 240.
trader - i meant worked on a M&A deal on the inside either as a banker or in a corporation? because going public or hostile isn't standard process. and you don't put pressure on them right before a conference call
i explained this a few years to one of the independent BOD. i might decide to revisit this with him in the future. Writing 6% ROE policies is bad business when you are trading at 1/2 of book with a good book of business in the portfolio. better to return capital.